Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Riluzole Serum Concentration in Pediatric Patients Treated for Obsessive-Compulsive Disorder.

Grant P, Farmer C, Song J, Kish T, Swedo S.

J Clin Psychopharmacol. 2017 Dec;37(6):713-716. doi: 10.1097/JCP.0000000000000797.

PMID:
29045303
2.

Overweight and obese status in children with autism spectrum disorder and disruptive behavior.

Criado KK, Sharp WG, McCracken CE, De Vinck-Baroody O, Dong L, Aman MG, McDougle CJ, McCracken JT, Eugene Arnold L, Weitzman C, Leventhal JM, Vitiello B, Scahill L.

Autism. 2017 Mar 1:1362361316683888. doi: 10.1177/1362361316683888. [Epub ahead of print]

PMID:
28325061
3.

Moderators of Parent Training for Disruptive Behaviors in Young Children with Autism Spectrum Disorder.

Lecavalier L, Smith T, Johnson C, Bearss K, Swiezy N, Aman MG, Sukhodolsky DG, Deng Y, Dziura J, Scahill L.

J Abnorm Child Psychol. 2017 Aug;45(6):1235-1245. doi: 10.1007/s10802-016-0233-x.

PMID:
27917460
4.

Lurasidone for the Treatment of Irritability Associated with Autistic Disorder.

Loebel A, Brams M, Goldman RS, Silva R, Hernandez D, Deng L, Mankoski R, Findling RL.

J Autism Dev Disord. 2016 Apr;46(4):1153-63. doi: 10.1007/s10803-015-2628-x.

5.

Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis.

Masi A, Lampit A, Glozier N, Hickie IB, Guastella AJ.

Transl Psychiatry. 2015 Sep 22;5:e640. doi: 10.1038/tp.2015.143.

6.

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.

Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, Vitiello B.

J Child Adolesc Psychopharmacol. 2015 Aug;25(6):482-93. doi: 10.1089/cap.2015.0005.

7.

Fluoxetine for Autistic Behaviors (FAB trial): study protocol for a randomized controlled trial in children and adolescents with autism.

Mouti A, Reddihough D, Marraffa C, Hazell P, Wray J, Lee K, Kohn M.

Trials. 2014 Jun 16;15:230. doi: 10.1186/1745-6215-15-230.

8.

The Brief Obsessive-Compulsive Scale (BOCS): a self-report scale for OCD and obsessive-compulsive related disorders.

Bejerot S, Edman G, Anckarsäter H, Berglund G, Gillberg C, Hofvander B, Humble MB, Mörtberg E, Råstam M, Ståhlberg O, Frisén L.

Nord J Psychiatry. 2014 Nov;68(8):549-59. doi: 10.3109/08039488.2014.884631. Epub 2014 Feb 25.

9.

An open-label extension study of the safety and efficacy of risperidone in children and adolescents with autistic disorder.

Kent JM, Hough D, Singh J, Karcher K, Pandina G.

J Child Adolesc Psychopharmacol. 2013 Dec;23(10):676-86. doi: 10.1089/cap.2012.0058.

10.

Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist.

Scahill L, Dimitropoulos A, McDougle CJ, Aman MG, Feurer ID, McCracken JT, Tierney E, Pu J, White S, Lecavalier L, Hallett V, Bearss K, King B, Arnold LE, Vitiello B.

J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):97-107.e1. doi: 10.1016/j.jaac.2013.09.018. Epub 2013 Oct 17.

11.

Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems.

Carroll D, Hallett V, McDougle CJ, Aman MG, McCracken JT, Tierney E, Arnold LE, Sukhodolsky DG, Lecavalier L, Handen BL, Swiezy N, Johnson C, Bearss K, Vitiello B, Scahill L.

Child Adolesc Psychiatr Clin N Am. 2014 Jan;23(1):57-72. doi: 10.1016/j.chc.2013.08.002.

12.

A genome scan for loci shared by autism spectrum disorder and language impairment.

Bartlett CW, Hou L, Flax JF, Hare A, Cheong SY, Fermano Z, Zimmerman-Bier B, Cartwright C, Azaro MA, Buyske S, Brzustowicz LM.

Am J Psychiatry. 2014 Jan;171(1):72-81. doi: 10.1176/appi.ajp.2013.12081103.

13.

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.

King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D.

JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698.

14.

Outcome measures for clinical trials in fragile X syndrome.

Berry-Kravis E, Hessl D, Abbeduto L, Reiss AL, Beckel-Mitchener A, Urv TK; Outcome Measures Working Groups.

J Dev Behav Pediatr. 2013 Sep;34(7):508-22. doi: 10.1097/DBP.0b013e31829d1f20.

15.

Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, Lane DM, Loveland KA, Bukstein OG, Jerger SW, Factor P, Vanwoerden S, Perez E, Cleveland LA.

J Child Adolesc Psychopharmacol. 2013 Jun;23(5):337-51. doi: 10.1089/cap.2012.0096.

16.

Pharmacotherapy for the core symptoms in autistic disorder: current status of the research.

Farmer C, Thurm A, Grant P.

Drugs. 2013 Mar;73(4):303-14. doi: 10.1007/s40265-013-0021-7. Review.

17.

Exploring the manifestations of anxiety in children with autism spectrum disorders.

Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, Dukes K, Vitiello B, Gadow K, Scahill L.

J Autism Dev Disord. 2013 Oct;43(10):2341-52. doi: 10.1007/s10803-013-1775-1.

18.

Psychiatric comorbidities in asperger syndrome and high functioning autism: diagnostic challenges.

Mazzone L, Ruta L, Reale L.

Ann Gen Psychiatry. 2012 Jun 25;11(1):16. doi: 10.1186/1744-859X-11-16.

19.

Pharmacologic treatment of repetitive behaviors in autism spectrum disorders: evidence of publication bias.

Carrasco M, Volkmar FR, Bloch MH.

Pediatrics. 2012 May;129(5):e1301-10. doi: 10.1542/peds.2011-3285. Epub 2012 Apr 23.

20.

Commentary on 'Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)'

Reiersen AM, Handen B.

Evid Based Child Health. 2011 Jul;6(4):1082-1085. No abstract available.

Supplemental Content

Support Center